AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Ep. 214 Ken Shreve: Improving Portfolio Health With Medical Stocks
Investing With IBD
Ion Endoluminal System
The R and D research and development, 53, uh, 0.8% on this one? That's pretty incredible. So you can kind of forgive the company for not being profitable because they're plowing a lot of that revenue into intoResearch and Development. The gap up on earnings, anytime a stock gaps up like intuitive surgical did and starts holding gains and, and trading sideways, means that the stock should be watched. It could just buy time underneath the 300 level here.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode